Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses.

Freeman D. et al, (2023), Lancet Psychiatry

Measuring dissociation across adolescence and adulthood: Developing the short-form Černis Felt Sense of Anomaly scale (ČEFSA-14)

Cernis E. et al, (2023), Behavioural and Cognitive Psychotherapy

Mode and site of action of therapies targeting CGRP signaling.

Labastida-Ramírez A. et al, (2023), J Headache Pain, 24

Investigating the relationship between sleep and migraine in a global sample: a Bayesian cross-sectional approach.

Stanyer EC. et al, (2023), J Headache Pain, 24

Long-term health consequences of congenital adrenal hyperplasia.

Pofi R. et al, (2023), Clin Endocrinol (Oxf)

The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.

McGurk KA. et al, (2023), Am J Hum Genet, 110, 1482 - 1495

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

Vahsen B. et al, (2023), Nature Communications

GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.

Lagou V. et al, (2023), Nat Genet, 55, 1448 - 1461

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Taquet M. et al, (2023), Nat Med

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Park J. et al, (2023), Genet Med

Disseminating cognitive behavioural therapy (CBT) for insomnia at scale: capitalising on the potential of digital CBT to deliver clinical guideline care.

Espie CA. and Henry AL., (2023), J Sleep Res

The Role of Inflammation in Age-Related Macular Degeneration-Therapeutic Landscapes in Geographic Atrophy.

Borchert GA. et al, (2023), Cells, 12

Cognitive behavioural therapy for insomnia disorder: Extending the stepped care model.

Baglioni C. et al, (2023), J Sleep Res

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.

Kyle SD. et al, (2023), Lancet

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial

KYLE S., (2023), The Lancet

Exercise promotes growth and rescues volume deficits in the hippocampus after cranial radiation in young mice.

Szulc-Lerch K. et al, (2023), NMR Biomed

Potential impact of wearables on physical activity guidelines and interventions: opportunities and challenges.

Gill JM. et al, (2023), Br J Sports Med

A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial.

Waite F. et al, (2023), Lancet Psychiatry

Weight Loss and Sleep, Current Evidence in Animal Models and Humans.

Gangitano E. et al, (2023), Nutrients, 15

A systematic review of the performance of actigraphy in measuring sleep stages

Yuan H. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»